Literature DB >> 11115362

Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.

J M Cruse1, R E Lewis, S Dilioglou.   

Abstract

Immune complex formation was induced by the injection of (125)I-BSA into female MRL/Mp lpr/lpr mice, which develop spontaneous systemic lupus erythematosus (SLE)-like disease, and MRL/Mp +/+ mice, which do not. At designated intervals following the injection of 10 mg of (125)I-bovine serum albumin (BSA), the nonlupus mice developed sparse, small electron-dense deposits in mesangial areas and subepithelial immune deposits that underwent partial resolution. By contrast, glomeruli of the SLE-prone mouse kidneys revealed proliferation of mesangial cells and some increase in mesangial matrix material. Numerous subepithelial and mesangial electron-dense deposits were present. Some subendothelial and intramembranous deposits were also demonstrated. Capillary lumens contained massive electron-dense deposits. The resolving subepithelial deposits observed were fewer than half the number found in kidneys of the non-SLE mice. Whole body counts were also recorded daily following the injection of (125)I-BSA. Whereas, both lupus-prone and non-SLE control mice eliminated (125)I-BSA at equivalent rates through day 12 postinoculation, those with SLE-like disease showed a decreased (125)I-BSA elimination rate between days 6 and 12. Results suggest an impairment in the ability of SLE-prone mice to resolve immune complexes, whether they are nuclear-antinuclear or from an exogenous source, i.e., BSA-anti-BSA, compared to controls in this experimental model of the superimposition of exogenous immune complex formation on systemic lupus erythematosus-like disease. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115362     DOI: 10.1006/exmp.2000.2330

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  4 in total

1.  IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.

Authors:  Paola Bossù; Detlef Neumann; Elda Del Giudice; Antonio Ciaramella; Isabelle Gloaguen; Giamila Fantuzzi; Charles A Dinarello; Emma Di Carlo; Piero Musiani; Pier Luigi Meroni; Gianfranco Caselli; Paolo Ruggiero; Diana Boraschi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

2.  Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.

Authors:  Jing Li; Xiaomei Leng; Zhijun Li; Zhizhong Ye; Caifeng Li; Xiaofeng Li; Ping Zhu; Zhengang Wang; Yi Zheng; Xiangpei Li; Miaojia Zhang; Xin-Ping Tian; Mengtao Li; Jiuliang Zhao; Feng-Chun Zhang; Yan Zhao; Xiaofeng Zeng
Journal:  J Immunol Res       Date:  2014-04-23       Impact factor: 4.818

3.  Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.

Authors:  Jon Von Visger; Clarissa Cassol; Uday Nori; Gerardo Franco-Ahumada; Tibor Nadasdy; Anjali A Satoskar
Journal:  BMC Nephrol       Date:  2019-02-14       Impact factor: 2.388

4.  Vascular Inflammation in Mouse Models of Systemic Lupus Erythematosus.

Authors:  Holly Ryan; Laurence Morel; Erika Moore
Journal:  Front Cardiovasc Med       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.